These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 2127400)

  • 41. Novel regulation of 5-HT1C receptors: down-regulation induced both by 5-HT1C/2 receptor agonists and antagonists.
    Pranzatelli MR; Murthy JN; Tailor PT
    Eur J Pharmacol; 1993 Jan; 244(1):1-5. PubMed ID: 8420788
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Behavioural evidence for a functional interaction between central 5-HT2 and 5-HT1A receptors.
    Backus LI; Sharp T; Grahame-Smith DG
    Br J Pharmacol; 1990 Aug; 100(4):793-9. PubMed ID: 2145051
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of 5-HT1C and 5-HT2 receptor stimulation on excessive grooming, penile erection and plasma oxytocin concentrations.
    Bagdy G; Kalogeras KT; Szemeredi K
    Eur J Pharmacol; 1992 Dec; 229(1):9-14. PubMed ID: 1473565
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of various serotonin receptor subtype-selective antagonists alone and on m-chlorophenylpiperazine-induced neuroendocrine changes in rats.
    Aulakh CS; Hill JL; Murphy DL
    J Pharmacol Exp Ther; 1992 Nov; 263(2):588-95. PubMed ID: 1432690
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Autoradiographic characterization of (+-)-1-(2,5-dimethoxy-4-[125I] iodophenyl)-2-aminopropane ([125I]DOI) binding to 5-HT2 and 5-HT1c receptors in rat brain.
    Appel NM; Mitchell WM; Garlick RK; Glennon RA; Teitler M; De Souza EB
    J Pharmacol Exp Ther; 1990 Nov; 255(2):843-57. PubMed ID: 2243353
    [TBL] [Abstract][Full Text] [Related]  

  • 46. 5-HT and carbohydrate suppression: effects of 5-HT antagonists on the action of d-fenfluramine and DOI.
    Lawton CL; Blundell JE
    Pharmacol Biochem Behav; 1993 Oct; 46(2):349-60. PubMed ID: 8265689
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pharmacological analysis of the cardiac effects of 5-HT and some 5-HT receptor agonists in the pithed rat.
    Dabiré H; Chaouche-Teyara K; Cherqui C; Fournier B; Schmitt H
    Fundam Clin Pharmacol; 1992; 6(6):237-45. PubMed ID: 1336759
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of the non-selective 5-HT receptor agonist, 5-carboxamidotryptamine, on plasma glucose levels in rats.
    Yamada J; Sugimoto Y; Noma T; Yoshikawa T
    Eur J Pharmacol; 1998 Oct; 359(1):81-6. PubMed ID: 9831297
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Involvement of 5-HT1C-receptors in drug-induced penile erections in rats.
    Berendsen HH; Jenck F; Broekkamp CL
    Psychopharmacology (Berl); 1990; 101(1):57-61. PubMed ID: 2343074
    [TBL] [Abstract][Full Text] [Related]  

  • 50. 5-HT2/5-HT1C receptor-mediated facilitatory action on unit activity of ventral horn cells in rat spinal cord slices.
    Yamazaki J; Fukuda H; Nagao T; Ono H
    Eur J Pharmacol; 1992 Sep; 220(2-3):237-42. PubMed ID: 1358651
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of atypical antipsychotic drugs on 5-HT2 receptors in the rat orbito-frontal cortex: an in vivo electrophysiological study.
    Bergqvist PB; Dong J; Blier P
    Psychopharmacology (Berl); 1999 Mar; 143(1):89-96. PubMed ID: 10227084
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Activation of 5-HT2A receptors impairs response control of rats in a five-choice serial reaction time task.
    Koskinen T; Ruotsalainen S; Puumala T; Lappalainen R; Koivisto E; Männistö PT; Sirviö J
    Neuropharmacology; 2000 Jan; 39(3):471-81. PubMed ID: 10698013
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Electrophysiological characterization of 5-hydroxytryptamine2 receptors in the rat medial prefrontal cortex.
    Ashby CR; Jiang LH; Kasser RJ; Wang RY
    J Pharmacol Exp Ther; 1990 Jan; 252(1):171-8. PubMed ID: 2137174
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Influence of 5-HT1 and 5-HT2 receptor antagonists on insulin-induced adrenomedullary catecholamine release.
    Chaouloff F; Gunn SH; Young JB
    Neuroendocrinology; 1991 Dec; 54(6):639-45. PubMed ID: 1784347
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Modulation of the 5-HT1C receptor-mediated behavior by 5-HT2, but not 5-HT1A, receptor activation.
    Chojnacka-Wójcik E
    Pol J Pharmacol Pharm; 1992; 44(5):427-36. PubMed ID: 1363616
    [TBL] [Abstract][Full Text] [Related]  

  • 56. 5-Hydroxytryptamine1C/2 agonists in the thoracic spinal cord: cardiovascular effects and binding sites in the intermediolateral cell column.
    Helke CJ; Thor KB; Phillips ET
    J Pharmacol Exp Ther; 1991 Dec; 259(3):1335-43. PubMed ID: 1762081
    [TBL] [Abstract][Full Text] [Related]  

  • 57. DOI-induced inhibition of copulatory behavior in male rats: reversal by 5-HT2 antagonists.
    Watson NV; Gorzalka BB
    Pharmacol Biochem Behav; 1991 Jul; 39(3):605-12. PubMed ID: 1784589
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Anxiogenic-like effects of mCPP and TFMPP in animal models are opposed by 5-HT1C receptor antagonists.
    Kennett GA; Whitton P; Shah K; Curzon G
    Eur J Pharmacol; 1989 May; 164(3):445-54. PubMed ID: 2767117
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The head-twitch response in the least shrew (Cryptotis parva) is a 5-HT2- and not a 5-HT1C-mediated phenomenon.
    Darmani NA; Mock OB; Towns LC; Gerdes CF
    Pharmacol Biochem Behav; 1994 Jun; 48(2):383-96. PubMed ID: 8090805
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pharmacological characterization of in vivo properties of putative mixed 5-HT1A agonist/5-HT(2A/2C) antagonist anxiolytics. II. Drug discrimination and behavioral observation studies in rats.
    Kleven MS; Assié MB; Koek W
    J Pharmacol Exp Ther; 1997 Aug; 282(2):747-59. PubMed ID: 9262338
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.